What are the major opportunities in the non-steroidal anti-inflammatory drugs market? What are the strategies for the non-steroidal anti-inflammatory drugs market?

For detailed insights on the major opportunities and strategies in the non-steroidal anti-inflammatory drugs market, Read More

How does the non-steroidal anti-inflammatory drugs market relate to the overall economy and other similar markets?

For detailed insights on non-steroidal anti-inflammatory drugs market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the non-steroidal anti-inflammatory drugs market growth? SWOT analysis of the non-steroidal anti-inflammatory drugs market.

For detailed insights on the key dynamics influencing the non-steroidal anti-inflammatory drugs market growth and SWOT analysis of the non-steroidal anti-inflammatory drugs industry, Read More

Non-Steroidal Anti-inflammatory Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Non-Steroidal Anti-inflammatory Drugs Market Report 2026

Name: Non-Steroidal Anti-inflammatory Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Route Of Administration (Oral, Topical, Other Route Of Administration), By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Non-Steroidal Anti-inflammatory Drugs Market Overview

• Non-Steroidal Anti-inflammatory Drugs market size has reached to $21.89 billion in 2025

• Expected to grow to $29.96 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%

• Growth Driver: Rising Prevalence Of Musculoskeletal Disorders To Drive Market Growth

• Market Trend: Product Innovations Transforming The Non-Steroidal Anti-Inflammatory Drugs Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Non-Steroidal Anti-inflammatory Drugs Market?

Non-steroidal anti-inflammatory drugs are medications that reduce inflammation and lower a fever. They are used to treat headaches, sprains and strains, painful periods, colds and flu, arthritis, and other long-term pain conditions, and to reduce inflammation, relieve pain, and bring down a high temperature.

The main routes of administration are oral, topical, and other routes of administration. Topical is used to ease muscle pains, sprains, and strains. They can also help ease painful arthritis. The disease indications are arthritis, migraine, ophthalmic diseases, and other diseases, and they are used in hospital pharmacies, retail pharmacies, and online pharmacies.

Non-Steroidal Anti-inflammatory Drugs Market Global Report 2026 Market Report bar graph

What Is The Non-Steroidal Anti-inflammatory Drugs Market Size and Share 2026?

The non-steroidal anti-inflammatory drugs market size has grown strongly in recent years. It will grow from $21.89 billion in 2025 to $23.31 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing prevalence of arthritis and musculoskeletal disorders, rising awareness of pain management therapies, growth in geriatric population, expansion of retail pharmacies, advancements in drug formulation technologies.

What Is The Non-Steroidal Anti-inflammatory Drugs Market Growth Forecast?

The non-steroidal anti-inflammatory drugs market size is expected to see strong growth in the next few years. It will grow to $29.96 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to adoption of personalized medicine, growth of e-pharmacy platforms, increasing r&d in novel nsaid formulations, rising incidence of chronic inflammatory diseases, integration of digital health solutions for pain monitoring. Major trends in the forecast period include personalized pain management solutions, rising demand for otc anti-inflammatory drugs, development of rapid-acting formulations, focus on chronic pain and arthritis management, expansion of online pharmacy channels.

Book your 30 minutes free consultation with our research experts

Global Non-Steroidal Anti-inflammatory Drugs Market Segmentation

1) By Route Of Administration: Oral, Topical, Other Route Of Administration

2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Oral: Tablets, Capsules, Liquids Or Solutions

2) By Topical: Gels, Creams, Patches

3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories

What Are The Drivers Of The Non-Steroidal Anti-inflammatory Drugs Market?

The increasing prevalence of musculoskeletal disorders is expected to propel the growth of the non-steroidal anti-inflammatory drug market going forward. Musculoskeletal disorders (MSDs) refer to a broad category of conditions that affect the musculoskeletal system, which includes the muscles, bones, tendons, ligaments, joints, and other connective tissues. Non-steroidal anti-inflammatory drugs (NSAIDs) play a crucial role in managing pain and inflammation associated with conditions like arthritis, osteoarthritis, and rheumatoid arthritis. Factors contributing to this growth include the aging population, increased awareness and diagnosis of musculoskeletal disorders, orthopedic procedures, sports injuries, and the chronic nature of these conditions. For instance, in January 2024, according to the GOV.UK, a UK-based government department, in 2023, 18.4% of individuals aged 16 and older reported having a long-term musculoskeletal (MSK) condition, marking an increase from the 17.6% prevalence recorded in 2022. Therefore, the increase in the increasing prevalence of musculoskeletal disorders is driving the growth of the non-steroidal anti-inflammatory drugs industry.

The rising prevalence of chronic pain is expected to drive the growth of the non-steroidal anti-inflammatory drugs (NSAIDs) market and related pain management solutions going forward. Chronic pain refers to persistent or recurrent pain lasting for three months or longer, which can result from conditions such as arthritis, fibromyalgia, back pain, neuropathic pain, and other musculoskeletal disorders. These conditions significantly affect patients’ quality of life and often require long-term management, including medication, physical therapy, and supportive care. The increasing prevalence of chronic pain boosts the demand for effective pain relief therapies, such as NSAIDs and other analgesic formulations. For instance, in October 2024, according to the National Center for Biotechnology Information, a US-based federal government research and information organization, 24.3% of adults reported experiencing chronic pain, while 8.5% of adults reported high-impact chronic pain that limits daily activities. Therefore, the growing number of individuals suffering from chronic pain is expected to drive the demand for pain management therapies, thereby supporting the growth of the NSAIDs market and related products.

Key Players In The Global Non-Steroidal Anti-inflammatory Drugs Market

Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company

Global Non-Steroidal Anti-inflammatory Drugs Market Trends and Insights

Major companies operating in the non-steroidal anti-inflammatory drugs (NSAIDs) market are focusing on developing innovative solutions, such as combination analgesic–gastroprotective formulations, to meet the rising demand for effective pain relief with reduced gastrointestinal risks commonly associated with long-term NSAID use. These combination technologies pair an NSAID with a protective agent to maintain anti-inflammatory efficacy while preventing stomach irritation, offering a safer alternative to traditional single-agent NSAIDs. For instance, in March 2024, Endo International plc, an Ireland-based pharmaceutical company, launched ibuprofen-famotidine 800 mg/26.6 mg tablets, an advanced formulation combining the analgesic and anti-inflammatory effects of ibuprofen with the gastroprotective action of famotidine. This dual-action tablet is designed to relieve pain while minimizing gastrointestinal side effects such as ulcers or irritation that often occur with prolonged NSAID therapy, providing enhanced safety and improved patient adherence.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Non-Steroidal Anti-inflammatory Drugs Market?

The non-steroidal anti-inflammatory drugs market consists of sales of high-dose aspirin, indomethacin, mefenamic acid, celecoxib, and other types. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Non-Steroidal Anti-inflammatory Drugs Market Report 2026?

The non-steroidal anti-inflammatory drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the non-steroidal anti-inflammatory drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Non-Steroidal Anti-inflammatory Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$23.31 billion
Revenue Forecast In 2035	$29.96 billion
Growth Rate	CAGR of 6.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Route Of Administration, Disease Indication, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sag
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Non-Steroidal Anti-inflammatory Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Non-Steroidal Anti-inflammatory Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Non-Steroidal Anti-inflammatory Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Non-Steroidal Anti-inflammatory Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Diitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Personalized Pain Management Solutions

4.2.2 Rising Demand For Otc Anti-Inflammatory Drugs

4.2.3 Development Of Rapid-Acting Formulations

4.2.4 Focus On Chronic Pain And Arthritis Management

4.2.5 Expansion Of Online Pharmacy Channels

5. Non-Steroidal Anti-inflammatory Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Retail Pharmacies

5.4 Online Pharmacies

5.5 Geriatric Care Centers

6. Non-Steroidal Anti-inflammatory Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-Steroidal Anti-inflammatory Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Non-Steroidal Anti-inflammatory Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Non-Steroidal Anti-inflammatory Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Non-Steroidal Anti-inflammatory Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Non-Steroidal Anti-inflammatory Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-Steroidal Anti-inflammatory Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-Steroidal Anti-inflammatory Drugs Market Segmentation

9.1. Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Topical, Other Route Of Administration

9.2. Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications

9.3. Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

9.4. Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tablets, Capsules, Liquids Or Solutions

9.5. Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Topical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gels, Creams, Patches

9.6. Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Other Route Of Administration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable (Intravenous And Intramuscular), Suppositories

10. Non-Steroidal Anti-inflammatory Drugs Market Regional And Country Analysis

10.1. Global Non-Steroidal Anti-inflammatory Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Non-Steroidal Anti-inflammatory Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-Steroidal Anti-inflammatory Drugs Market

11.1. Asia-Pacific Non-Steroidal Anti-inflammatory Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-Steroidal Anti-inflammatory Drugs Market

12.1. China Non-Steroidal Anti-inflammatory Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-Steroidal Anti-inflammatory Drugs Market

13.1. India Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-Steroidal Anti-inflammatory Drugs Market

14.1. Japan Non-Steroidal Anti-inflammatory Drugs Market Overview

14.2. Japan Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-Steroidal Anti-inflammatory Drugs Market

15.1. Australia Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-Steroidal Anti-inflammatory Drugs Market

16.1. Indonesia Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-Steroidal Anti-inflammatory Drugs Market

17.1. South Korea Non-Steroidal Anti-inflammatory Drugs Market Overview

17.2. South Korea Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-Steroidal Anti-inflammatory Drugs Market

18.1. Taiwan Non-Steroidal Anti-inflammatory Drugs Market Overview

18.2. Taiwan Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-Steroidal Anti-inflammatory Drugs Market

19.1. South East Asia Non-Steroidal Anti-inflammatory Drugs Market Overview

19.2. South East Asia Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-Steroidal Anti-inflammatory Drugs Market

20.1. Western Europe Non-Steroidal Anti-inflammatory Drugs Market Overview

20.2. Western Europe Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-Steroidal Anti-inflammatory Drugs Market

21.1. UK Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-Steroidal Anti-inflammatory Drugs Market

22.1. Germany Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-Steroidal Anti-inflammatory Drugs Market

23.1. France Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-Steroidal Anti-inflammatory Drugs Market

24.1. Italy Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-Steroidal Anti-inflammatory Drugs Market

25.1. Spain Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-Steroidal Anti-inflammatory Drugs Market

26.1. Eastern Europe Non-Steroidal Anti-inflammatory Drugs Market Overview

26.2. Eastern Europe Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-Steroidal Anti-inflammatory Drugs Market

27.1. Russia Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-Steroidal Anti-inflammatory Drugs Market

28.1. North America Non-Steroidal Anti-inflammatory Drugs Market Overview

28.2. North America Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-Steroidal Anti-inflammatory Drugs Market

29.1. USA Non-Steroidal Anti-inflammatory Drugs Market Overview

29.2. USA Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-Steroidal Anti-inflammatory Drugs Market

30.1. Canada Non-Steroidal Anti-inflammatory Drugs Market Overview

30.2. Canada Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-Steroidal Anti-inflammatory Drugs Market

31.1. South America Non-Steroidal Anti-inflammatory Drugs Market Overview

31.2. South America Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-Steroidal Anti-inflammatory Drugs Market

32.1. Brazil Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-Steroidal Anti-inflammatory Drugs Market

33.1. Middle East Non-Steroidal Anti-inflammatory Drugs Market Overview

33.2. Middle East Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-Steroidal Anti-inflammatory Drugs Market

34.1. Africa Non-Steroidal Anti-inflammatory Drugs Market Overview

34.2. Africa Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-Steroidal Anti-inflammatory Drugs Market Regulatory and Investment Landscape

36. Non-Steroidal Anti-inflammatory Drugs Market Competitive Landscape And Company Profiles

36.1. Non-Steroidal Anti-inflammatory Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Non-Steroidal Anti-inflammatory Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Non-Steroidal Anti-inflammatory Drugs Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Assertio Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Non-Steroidal Anti-inflammatory Drugs Market Other Major And Innovative Companies

Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A.

38. Global Non-Steroidal Anti-inflammatory Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-Steroidal Anti-inflammatory Drugs Market

40. Non-Steroidal Anti-inflammatory Drugs Market High Potential Countries, Segments and Strategies

40.1 Non-Steroidal Anti-inflammatory Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Non-Steroidal Anti-inflammatory Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Non-Steroidal Anti-inflammatory Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Non-Steroidal Anti-inflammatory Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Non-Steroidal Anti-inflammatory Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Non-Steroidal Anti-inflammatory Drugs Market, Supply Chain Analysis

Table 4: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Raw Material Providers

Table 5: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Resource Providers

Table 6: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Distributors And Channel Partners

Table 8: Global Non-Steroidal Anti-inflammatory Drugs Market, Key Technologies & Future Trends

Table 9: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Trends

Table 10: Global Non-Steroidal Anti-inflammatory Drugs Market, Major End Users

Table 11: Global Non-Steroidal Anti-inflammatory Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Non-Steroidal Anti-inflammatory Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Non-Steroidal Anti-inflammatory Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Non-Steroidal Anti-inflammatory Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Topical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Other Route Of Administration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Non-Steroidal Anti-inflammatory Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Non-Steroidal Anti-inflammatory Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Non-Steroidal Anti-inflammatory Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Non-Steroidal Anti-inflammatory Drugs Market - Company Scoring Matrix

Table 97: Pfizer Inc. Financial Performance

Table 98: Bayer AG Financial Performance

Table 99: Johnson & Johnson Financial Performance

Table 100: Sun Pharmaceutical Industries Ltd. Financial Performance

Table 101: Assertio Therapeutics Inc. Financial Performance

Table 102: Global Non-Steroidal Anti-inflammatory Drugs Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Non-Steroidal Anti-inflammatory Drugs Market, Competitive Dashboard

Table 104: Global Non-Steroidal Anti-inflammatory Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Non-Steroidal Anti-inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 106: Global, Non-Steroidal Anti-inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Table 107: Global, Non-Steroidal Anti-inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Non-Steroidal Anti-inflammatory Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Non-Steroidal Anti-inflammatory Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Non-Steroidal Anti-inflammatory Drugs Market, Supply Chain Analysis

Figure 4: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Raw Material Providers

Figure 5: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Resource Providers

Figure 6: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Non-Steroidal Anti-inflammatory Drugs Market, Key Technologies & Future Trends

Figure 9: Global Non-Steroidal Anti-inflammatory Drugs Market, Major Trends

Figure 10: Global Non-Steroidal Anti-inflammatory Drugs Market, Major End Users

Figure 11: Global Non-Steroidal Anti-inflammatory Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Non-Steroidal Anti-inflammatory Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Non-Steroidal Anti-inflammatory Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Non-Steroidal Anti-inflammatory Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Topical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Other Route Of Administration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Non-Steroidal Anti-inflammatory Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Non-Steroidal Anti-inflammatory Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Non-Steroidal Anti-inflammatory Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Non-Steroidal Anti-inflammatory Drugs Market - Company Scoring Matrix

Figure 97: Pfizer Inc. Financial Performance

Figure 98: Bayer AG Financial Performance

Figure 99: Johnson & Johnson Financial Performance

Figure 100: Sun Pharmaceutical Industries Ltd. Financial Performance

Figure 101: Assertio Therapeutics Inc. Financial Performance

Figure 102: Global Non-Steroidal Anti-inflammatory Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Non-Steroidal Anti-inflammatory Drugs Market, Competitive Dashboard

Figure 104: Global Non-Steroidal Anti-inflammatory Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Non-Steroidal Anti-inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 106: Global, Non-Steroidal Anti-inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Figure 107: Global, Non-Steroidal Anti-inflammatory Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Teleradiology Market Report 2026 - Global Outlook – By Modality (X-Ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Ultrasound Systems), By Technology (Web Based, Cloud Based), By Component (Hardware...

Docks Construction Market Report 2026 - Global Outlook – By Type (Fixed Docks, Floating Docks), By Installation (Residential, Commercial, Industrial, Institutional), By Application (Marinas And Waterfront Recreation, Mar...

Employee Monitoring Software Market Report 2026 - Global Outlook – By Type (Premises Employee Monitoring, Remote Employee Monitoring), By Deployment Mode (Hybrid, Cloud Based, On-Premises), By Features (Productivity Moni...

Docks Construction Market Report 2026 - Global Outlook – By Type (Fixed Docks, Floating Docks), By Installation (Residential, Commercial, Industrial, Institutional), By Application (Marinas And Waterfront Recreation, Mar...

Frequently Asked Questions

How big is the Non-Steroidal Anti-inflammatory Drugs Market?

The Non-Steroidal Anti-inflammatory Drugs market was valued at $21.89 billion in 2025, increased to $23.31 billion in 2026, and is projected to reach $29.96 billion by 2030.

What is the Non-Steroidal Anti-inflammatory Drugs market growth?

The global Non-Steroidal Anti-inflammatory Drugs market is expected to grow at a CAGR of 6.5% from 2026 to 2035 to reach $29.96 billion by 2035.

Who are the key players in Non-Steroidal Anti-inflammatory Drugs market?

Some Key Players in the Non-Steroidal Anti-inflammatory Drugs market Include, Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceutic

Major trend in this market includes: Product Innovations Transforming The Non-Steroidal Anti-Inflammatory Drugs Market. For further insights on this market. request a sample here

North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The r

Book your 30 minutes free consultation with our research experts

Contact Us